Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Scleroderma
NCT00740285Phase 3Completed
- Sponsor
- Federal University of São Paulo
- Start
- Apr 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in scleroderma, sponsored by Federal University of São Paulo. Started Apr 2004; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
scleroderma
Beyond the preview
Go deeper on NCT00740285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740285.